Investors in Healthcare

Artificial intelligence is already reshaping workflows and productivity across all industries. The implications for value creation, however, are far from uniform. Filippos Papadopoulos, senior analyst, Seren Marsh, clinical fellow, and Henry Elphick, chair, of Mansfield Advisors examine how investors should assess “AI exposure” across healthcare, life sciences and social care. Walk the floor of any healthtech conference today and you’ll hear two stories told with equal conviction. The first is the hype narrative: AI will transform everything, from triage to treatment to drug discovery, and investors would be missing out...